It is a broadly described annual report (board’s report) of Glenmark Pharmaceuticals Limited in the year of 2016-2017. During the financial year, Total assets of the Company stood at Rs. 117,638.67 million. The Company achieved gross revenue of Rs. 92,230.46 million and the operating profit before finance costs, depreciation & tax was Rs. 20,740.65 million as compared to Rs. 14,571.52 million in the previous year. The Company posted Profit before tax for the year at Rs. 14,914.30 million as compared Rs. 10,439.83 million in the previous year. Profit after Tax of the Company for the year at Rs. 11,087.53 million as compared Rs. 7,430.45 million in the previous year. The earnings per share (EPS) for the year ended on 2017 was Rs. 39.29.
The Board of Directors of the Company has recommended a Dividend of @200% (Rs. 2/- per equity share of Rs. 1/- each) to be appropriated from the profits of the year 2016-2017.
More Annual Report of Glenmark Pharmaceuticals Limited: